U.S.: China De Minimis Gone + New Tariffs

This April 2025 US Executive Order further targets synthetic opioid imports from China, suspending de minimis duty exemptions and imposing new tariffs.

U.S. officials analyze international trade data and monitor compliance with the April 2025 Executive Order on synthetic opioid imports, implementing stricter tariffs and controls on shipments from China.

The Executive Order issued on April 2, 2025, addresses the issue of synthetic opioids being shipped from the People's Republic of China (PRC) and Hong Kong to the United States through deceptive shipping practices, often utilizing the de minimis exemption under section 321(a)(2)(C) of the Tariff Act of 1930.

The order introduces further amendments to duties related to these imports in light of the ongoing synthetic opioid crisis.

Questions We Answer In This Blog:

ChatGPT said:

1. What is the suspension of duty-free de minimis treatment?

2. How will low-value products from the PRC and Hong Kong be affected?

3. What changes will apply to postal shipments from the PRC and Hong Kong?

4. What are the carrier requirements under this new order?

5. Is there a bond requirement for carriers?

6. When can CBP require formal entry?

7. How will the implementation and monitoring of this order work?

Downloads:

Download the new executive order

Executive Summary

Want to read more?

Subscribe to customsmanager.info to keep reading this exclusive post.

Subscribe Now